Duos Technologies Featured Sponsor at Rail Insights 2024
June 13, 2024 08:00 ET
|
Duos Technologies Group, Inc
Duos Technologies Featured Sponsor at Rail Insights 2024
Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
June 11, 2024 15:30 ET
|
Tevogen Bio Inc
Agreement for Up to $50 Million in Financing. Includes $36 million line of credit and potential $14 million private placement.
Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
May 30, 2024 08:00 ET
|
Anaqua
IP Management software company Anaqua today announces a lineup of IP speakers and panelists for its 15th annual Anaqua Experience Conference (AEC).
Groundbreaking Technology Solves Major Problem of User Lockouts During MFA Resets
May 30, 2024 08:00 ET
|
NAMETAG INC.
Nametag patents breakthrough technology that eliminates frustration and security risks associated with resetting multi-factor authentication tokens.
CarbonMeta Technologies Files Provisional Patent for Tracking Captured CO2 in Concrete Using Blockchain Technology
May 28, 2024 08:30 ET
|
CarbonMeta Technologies, Inc.
Woodinville, WA, USA, May 28, 2024 (GLOBE NEWSWIRE) -- CarbonMeta Technologies Inc. (OTC PINK:COWI, “CarbonMeta”), a pioneering green technology company, today announced the filing of a...
Rail Vision Received Notice of Allowance for US Patent on AI-Powered Railway Obstacle Detection System
May 21, 2024 09:19 ET
|
Rail Vision Ltd.
Ra’anana, Israel, May 21, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related...
U.S. Patent and Trademark Office Grants US Patent # 11,975,112 for “Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine”
May 20, 2024 10:36 ET
|
Starton Therapeutics
Olanzapine (ZYPREXA®) is an antipsychotic medication used to treat schizophrenia and bipolar disorder that is commonly used as anti-nausea off label medication.Olanzapine has been investigated for use...
AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036
May 13, 2024 12:08 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LA DÉLIVRANCE D'UN BREVET EUROPÉEN POUR LE MASITINIB DANS LE TRAITEMENT DE LA MASTOCYTOSE SÉVÈRE AVEC UNE PROTECTION JUSQU'EN 2036 ...
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
May 13, 2024 12:08 ET
|
AB Science
PRESS RELEASE AB SCIENCE ANNOUNCES ISSUANCE OF A EUROPEAN PATENT FOR MASITINIB IN THE TREATMENT OF SEVERE MASTOCYTOSIS WITH PROTECTION UNTIL 2036 Paris, May 13, 2024, 6pm CET AB Science SA...
Anaqua présente la version 8 de PATTSY WAVE, son logiciel de gestion de la propriété intellectuelle
May 07, 2024 08:00 ET
|
Anaqua
BOSTON, 07 mai 2024 (GLOBE NEWSWIRE) -- Anaqua, leader des technologies de gestion de la propriété intellectuelle (PI) et de l’innovation, lance dès aujourd’hui la version 8 de PATTSY WAVE. Il...